HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DTC Men’s Health Product Brand Roman Reaches In-Store Sales With Supplements Sold At Walmart

Executive Summary

A month after closing its largest funding round, Roman Health' says its daily vitamins and supplements for heart health, stress relief, testosterone support, prostate health and a multivitamin will be available in Walmart stores and in the retail giant’s e-commerce platform on 1 May.

You may also be interested in...



Telehealth Firm Ro Talks More Than ED But Still DTC With Further Consumer Health Expansion

Ro acquires Dadi  specializing in sperm testing, analysis and storage, two weeks after adding $150m funding and 10 months after entering female fertility product market with acquisition of Modern Fertility.

Distributing Health, Beauty Products To Retailers, Hims & Hers Seeds Field For OTC ED Drug Sales

With ED ingredients frequently mentioned as OTC switch candidates in US, Hims & Hers Health is another latest direct-to-consumer marketer establishing network of retailers to offer potential OTC ED drug as it makes its consumer health and personal care products available in stores.

Legacy Consumer Health Firms Invest To Compete In Startups' Realm: E-Commerce

J&J, Colgate, P&G and Church & Dwight look to e-commerce to regain market share from smaller, nimble consumer health brands and digital-based retail startups, executives from the firms say at Barclays Global Consumer Staples conference.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS151267

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel